What is necrotising fasciitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Necrotising Fasciitis?

Necrotising fasciitis is a rare, life-threatening bacterial infection that rapidly destroys the superficial fascia (subcutaneous tissue between skin and muscle), tracking along fascial planes and extending well beyond visible skin changes. 1

Pathophysiology and Tissue Involvement

The term "fasciitis" refers specifically to the superficial fascia—all tissue between the skin and underlying muscles—not the muscular fascia or aponeurosis. 1 The infection is characterized by:

  • Rapid spreading necrosis of the fascia, subcutaneous fat, and overlying skin 2, 3
  • Fulminant tissue destruction of poorly blood-supplied muscle fascia 4
  • Extension along fascial planes that spreads well beyond superficial signs like erythema 1

Microbiological Classification

Necrotising fasciitis is classified into three distinct types based on causative organisms:

Type I (Polymicrobial)

  • Caused by multiple aerobic and anaerobic organisms, averaging 5 pathogens per wound (up to 15 different microorganisms) 5
  • Associated with: intestinal surgery, penetrating abdominal trauma, decubitus ulcers, perianal abscesses, injection drug use sites, Bartholin gland abscesses 5

Type II (Monomicrobial)

  • Caused by single pathogens: Streptococcus pyogenes (most common), Staphylococcus aureus, Vibrio vulnificus, Aeromonas hydrophila, or anaerobic streptococci 1, 5
  • Can occur in any age group and in immunologically healthy individuals 5, 6

Type III (Clostridial)

  • Caused by Clostridium or Bacillus species 5
  • Characterized by gas in tissues and acute infection of healthy tissue 5

Clinical Presentation

Initial Presentation (80% of cases)

Extension from a trivial skin lesion such as minor abrasion, insect bite, injection site, or boil 1 The remaining 20% have no visible skin lesion. 1

Cardinal Clinical Features

Pain disproportionate to physical findings is the hallmark early symptom that distinguishes necrotising fasciitis from simple cellulitis. 7, 8, 5

The "wooden-hard" feel of subcutaneous tissues is the most distinguishing physical finding—unlike cellulitis where tissues remain palpable and yielding, in fasciitis the fascial planes and muscle groups cannot be discerned by palpation. 1, 8

Frequency of Clinical Signs

  • Cellulitis/erythema: 90% of cases 1
  • Edema: 80% of cases 1, 7
  • Skin discoloration or gangrene: 70% of cases 1
  • Anesthesia of involved skin: frequent but true incidence unknown 1
  • Crepitus (gas in tissues): present but appears in only a minority of early cases 8

Systemic Features

  • High fever with systemic toxicity 1
  • Altered mental status, disorientation, lethargy 1, 8
  • Hypotension and septic shock in advanced cases 7

Late Findings (Often Missed Early)

  • Skin necrosis or ecchymoses: present in only 0-5% at initial presentation, increasing to 9-36% by day 4 8
  • Bullous lesions accompanying skin necrosis 7
  • Broad erythematous tract along the route of infection as it advances 1

Anatomic Distribution and Risk Factors

Approximately two-thirds of cases involve the lower extremities, making leg trauma a high-risk scenario. 7 Most infections are community-acquired. 1

Underlying predisposing conditions include:

  • Diabetes mellitus 1
  • Arteriosclerotic vascular disease 1
  • Venous insufficiency with edema 1
  • Chronic vascular ulcers 1

Diagnostic Challenges

Early diagnosis is missed or delayed in 85-100% of cases because the disease lacks specific clinical features in the initial stage and is often confused with cellulitis or abscess. 2 The infection initially presents as cellulitis that can advance rapidly or slowly. 1

A high index of clinical suspicion remains the most important diagnostic tool—more critical than any laboratory test or imaging study. 2, 8

Prognosis

Mortality rates remain high and have shown no tendency to decrease over the past century. 2 In patients who progress to hypotension and multi-organ failure, mortality rates rise to 50-70%. 7

Each hour of delay in surgical intervention is associated with increased mortality, making this a true medical and surgical emergency. 7, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Necrotizing fasciitis: classification, diagnosis, and management.

The journal of trauma and acute care surgery, 2012

Research

Necrotizing fasciitis: pathophysiology and treatment.

Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses, 2002

Guideline

Fascitis Necrotizante: Clasificación y Tratamiento

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Differential Diagnoses for Necrotizing Fasciitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline for Differentiating Necrotizing Fasciitis from Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

How is necrotizing fasciitis diagnosed in a patient with a history of trauma, compromised immune system, or recent surgery, presenting with severe pain, swelling, and erythema?
How to diagnose necrotizing fasciitis?
What are the types of necrotizing fasciitis?
What are the differential diagnoses for necrotizing fascitis?
What is the treatment for necrotizing fasciitis in pediatric patients?
What are the indications for central venous catheters, how can catheter‑related bloodstream infections be prevented, what complications should be monitored, what is the appropriate dressing‑change protocol, and how should blood cultures be obtained from a central line?
What causes a lung to fail to re‑expand after drainage of a massive pleural effusion, and what is the appropriate diagnostic and management approach?
In a patient with chronic kidney disease and hyperphosphatemia, when should calcium acetate be used instead of sevelamer (or vice versa) as a phosphate binder, considering serum calcium level, vascular calcification, bone disease, dialysis calcium load, and other contraindications?
How should I manage a patient with atrial fibrillation, including assessment of hemodynamic stability, anticoagulation, rate control, and rhythm control?
In a male patient over 50 presenting with lower urinary tract symptoms, how should I differentiate benign prostatic hyperplasia (BPH) from prostate cancer and what is the appropriate diagnostic workup?
How should I evaluate and manage a 26-year-old woman with new-onset involuntary vocalizations (e.g., grunting, shouting, throat clearing) after recent septicemia and a history of anxiety?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.